The FDA has already approved one of the medications, with a decision on another expected by the end of April. 

The two single-use devices are now approved for the treatment of pediatric AVNRT.

The solution, which gained FDA clearance in November 2021, is now being used by specialists at the University of California San Diego Health.

The study's authors suspect their findings could improve patient selection for CIEDs. 

Researchers examined data on more than 3,400 BP devices used all over the world. A significant majority of them were never clinically validated for accuracy. 

Learn more about the late-breaking studies presented at ACC.22 in Washington, D.C. 

A key takeaway from the group's analysis was that the rate of major bleeding events did not significantly change. 

Sixty-two percent of those surveyed believe significant reliance on other countries for medicines is among the biggest contributing factor to medicine shortages, according to new survey results.